Όλο το DSpace

Πλοήγηση ανά Θέμα "nucleus accumbens"

Αποτελέσματα 1-4 από 4

    • Antidepressants influence somatostatin levels and receptor pharmacology in brain 

      Pallis, E.; Vasilaki, A.; Fehlmann, D.; Kastellakis, A.; Hoyer, D.; Spyraki, C.; Thermos, K. (2009)
      This study investigated how the administration (acute and chronic) of the antidepressants citalopram and desmethylimipramine (DMI) influences somatostatin (somatotropin release inhibitory factor, SRIF) levels and SRIF ...

    • Brain volume dynamics in multiple sclerosis. A case-control study 

      Andravizou A., Artemiadis A., Bakirtzis C., Siokas V., Aloizou A.-M., Peristeri E., Kapsalaki E., Tsimourtou V., Hadjigeorgiou G.M., Dardiotis E. (2019)
      Objectives: In this study, we aimed to explore the extent and clinical relevance of brain volume dynamics in relapsing remitting multiple sclerosis (RRMS). Methods: Sixty-three patients with RRMS with a disease duration ...

    • Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg? 

      Andravizou A., Siokas V., Artemiadis A., Bakirtzis C., Aloizou A.-M., Grigoriadis N., Kosmidis M.H., Nasios G., Messinis L., Hadjigeorgiou G., Dardiotis E., Peristeri E. (2020)
      Objectives: Cognitive impairment is common in multiple sclerosis, but the brain MRI correlates in relapsing remitting multiple sclerosis remain controversial. The current study aimed to investigate whether cognitive decline ...

    • Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence from the COURAGE-PD Consortium 

      Grover S., Sreelatha A.A.K., Pihlstrom L., Domenighetti C., Schulte C., Sugier P.-E., Radivojkov-Blagojevic M., Lichtner P., Mohamed O., Portugal B., Landoulsi Z., May P., Bobbili D., Edsall C., Bartusch F., Hanussek M., Krüger J., Hernandez D.G., Blauwendraat C., Mellick G.D., Zimprich A., Pirker W., Tan M., Rogaeva E., Lang A., Koks S., Taba P., Lesage S., Brice A., Corvol J.-C., Chartier-Harlin M.-C., Mutez E., Brockmann K., Deutschländer A.B., Hadjigeorgiou G.M., Dardiotis E., Stefanis L., Simitsi A.M., Valente E.M., Petrucci S., Straniero L., Zecchinelli A., Pezzoli G., Brighina L., Ferrarese C., Annesi G., Quattrone A., Gagliardi M., Burbulla L.F., Matsuo H., Kawamura Y., Hattori N., Nishioka K., Chung S.J., Kim Y.J., Pavelka L., Van De Warrenburg B.P.C., Bloem B.R., Singleton A.B., Aasly J., Toft M., Guedes L.C., Ferreira J.J., Bardien S., Carr J., Tolosa E., Ezquerra M., Pastor P., Diez-Fairen M., Wirdefeldt K., Pedersen N.L., Ran C., Belin A.C., Puschmann A., Hellberg C., Clarke C.E., Morrison K.E., Krainc D., Farrer M.J., Kruger R., Elbaz A., Gasser T., Sharma M. (2022)
      Background and Objectives Considerable heterogeneity exists in the literature concerning genetic determinants of the age at onset (AAO) of Parkinson disease (PD), which could be attributed to a lack of well-powered replication ...